Therefore, an in-depth exploration of the mechanism of action of ESRP1 in breast cancer and the development of targeted therapeutic drugs against ESRP1 are expected to provide new perspectives and strategies for the diagnosis, treatment, and prognosis of breast cancer. This evidence concerns the gene ESRP1 and breast cancer.